DE3370283D1 - Composition for tumour reversion and its use in cancerology - Google Patents

Composition for tumour reversion and its use in cancerology

Info

Publication number
DE3370283D1
DE3370283D1 DE8383400095T DE3370283T DE3370283D1 DE 3370283 D1 DE3370283 D1 DE 3370283D1 DE 8383400095 T DE8383400095 T DE 8383400095T DE 3370283 T DE3370283 T DE 3370283T DE 3370283 D1 DE3370283 D1 DE 3370283D1
Authority
DE
Germany
Prior art keywords
cancerology
composition
reversion
tumour
tumour reversion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8383400095T
Other languages
English (en)
Inventor
Roger Louis Eugene Bocquet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE3370283D1 publication Critical patent/DE3370283D1/de
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
DE8383400095T 1982-01-29 1983-01-14 Composition for tumour reversion and its use in cancerology Expired DE3370283D1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8201397A FR2520619A1 (fr) 1982-01-29 1982-01-29 Composition revertante basee sur l'association polyethylene glycol-dimethylsulfoxyde-theophylline et son emploi en cancerologie

Publications (1)

Publication Number Publication Date
DE3370283D1 true DE3370283D1 (en) 1987-04-23

Family

ID=9270449

Family Applications (2)

Application Number Title Priority Date Filing Date
DE198383400095T Pending DE86122T1 (de) 1982-01-29 1983-01-14 Zusammensetzung zur tumorumkehrung und ihre verwendung in der krebsforschung.
DE8383400095T Expired DE3370283D1 (en) 1982-01-29 1983-01-14 Composition for tumour reversion and its use in cancerology

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE198383400095T Pending DE86122T1 (de) 1982-01-29 1983-01-14 Zusammensetzung zur tumorumkehrung und ihre verwendung in der krebsforschung.

Country Status (8)

Country Link
US (1) US4767763A (de)
EP (1) EP0086122B1 (de)
JP (1) JPS58146510A (de)
CA (1) CA1188226A (de)
DE (2) DE86122T1 (de)
FR (1) FR2520619A1 (de)
IL (1) IL67748A (de)
ZA (1) ZA83396B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9417742D0 (en) * 1994-09-03 1994-10-19 Univ Nottingham Macrophage stimulating composition
JP2008308473A (ja) * 2007-06-18 2008-12-25 Japan Health Science Foundation 癌治療剤
FR3012037B1 (fr) * 2013-10-23 2016-05-20 Herve Edouard Henri Jeambourquin Solution révertante à base de diméthylsulfoxyde et de polyéthylène-glycol

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA824650A (en) * 1969-10-07 Desjardins Roger Suppository
GB1043012A (en) * 1964-07-28 1966-09-21 Ici Ltd Pharmaceutical compositions comprising tumour-growth-inhibitory agents

Also Published As

Publication number Publication date
DE86122T1 (de) 1983-11-24
FR2520619B1 (de) 1984-04-06
US4767763A (en) 1988-08-30
EP0086122A1 (de) 1983-08-17
CA1188226A (en) 1985-06-04
IL67748A0 (en) 1983-05-15
ZA83396B (en) 1983-10-26
JPS58146510A (ja) 1983-09-01
JPH0460093B2 (de) 1992-09-25
IL67748A (en) 1986-01-31
EP0086122B1 (de) 1987-03-18
FR2520619A1 (fr) 1983-08-05

Similar Documents

Publication Publication Date Title
DE3372705D1 (en) Pharmaceutical composition and its use
EP0097960A3 (en) Bis-crown-ether derivatives and their use
PL240077A1 (en) Container in particular for medical purposes
EP0428188A3 (en) Novel immunoconjugates and methods for their use in tumor therapy
PH18810A (en) Novel composition useful in cosmetic and medicine
GB2047536B (en) Dihydroxycholecalciferols for use in regulating bone metabolism
GB2132996B (en) Oral composition and abrasive therefor
JPS5618979A (en) Indolizine derivative* its manufacture and medicine containing it
GB2065631B (en) Despersant and biodegradant formulations
JPS5649317A (en) Antiallergic composition for absorbing minerals and its use
GB2122864B (en) Improvements in straw treatment
DE3067652D1 (en) Improvements in the treatment of hazardous waste
GB2098478B (en) Propioibacteria preparations for use in the treatment of tumours
DE3068444D1 (en) Improvements in wheelchairs
GB2047534B (en) Analgesic and myotonolytic compositions
JPS5748914A (en) Tumor inhibiting pharmaceutical composition and use thereof
GB2051069B (en) Phospholipid derivatives useful in therapy as antilepaemics and antiarteriosclerotics and compositions containing them
DE3370283D1 (en) Composition for tumour reversion and its use in cancerology
GB2119803B (en) Products for use in treating cancer
GB2131293B (en) Composition containing dextran for use in medical treatment
GB2133056B (en) Improvements in and/or relating to cribwalling
JPS56103118A (en) Radioactivity assey and useful composition therefor
GB2088715B (en) Improvements in swine husbandry and composition therefor
GB2019720B (en) Adenosyl-l-homocysteine and salts thereof for use in therapy
DE3374560D1 (en) Cyanoalkylpiperazines and methods for their preparation and use

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee